ABSTRACT
BACKGROUND: Breast fibromatosis is a rare clinical entity, but poses significant diagnostic and therapeutic challenges. In light of recent changes in management practices, the aim was to review our institutional experience of breast fibromatosis and provide a review of current available literature on such management. METHODS: A search of pathological databases within two tertiary institutions for all patients diagnosed with fibromatosis of the breast over a 10-year period (2007-2016) was performed. Clinicopathological characteristics and modes of treatment were recorded for each patient. Concurrently a comprehensive literature search was performed and studies relating to breast fibromatosis and its management were identified and reviewed. RESULTS: Sixteen patients were identified. Median age at diagnosis was 42 (range 21-70) and all patients were diagnosed with core biopsy. The most useful imaging modality in diagnosis was ultrasonography and magnetic resonance imaging. 13/16 were treated surgically whilst 3/16 were treated using a watch-and-wait approach. 6/13 (46%) required re-excision of margins and 2/13 (15%) had recurrence after surgery. On review of the literature, there is no dedicated guideline in place for the management of breast fibromatosis. Currently a 'watch and wait' approach is favoured over surgical intervention due to high levels of recurrence and associated surgical morbidity. All cases should be discussed at a sarcoma multidisciplinary team meeting and tyrosine kinase inhibitors should be considered in advanced cases. CONCLUSIONS: Breast fibromatosis is rare but affects young patients. Active surveillance is now favoured over surgical resection due to high recurrence rates and extensive morbidity. Dedicated guidelines are required to ensure best outcomes.
Subject(s)
Breast Neoplasms/therapy , Fibroma/therapy , Mastectomy/statistics & numerical data , Neoplasm Recurrence, Local/epidemiology , Watchful Waiting/statistics & numerical data , Adult , Aged , Biopsy, Large-Core Needle , Breast/diagnostic imaging , Breast/pathology , Breast/surgery , Breast Neoplasms/diagnosis , Breast Neoplasms/epidemiology , Breast Neoplasms/pathology , Female , Fibroma/diagnosis , Fibroma/epidemiology , Fibroma/pathology , Humans , Magnetic Resonance Imaging , Mastectomy/adverse effects , Mastectomy/standards , Middle Aged , Neoplasm Recurrence, Local/prevention & control , Postoperative Complications/epidemiology , Postoperative Complications/etiology , Postoperative Complications/prevention & control , Practice Guidelines as Topic , Reoperation/statistics & numerical data , Ultrasonography, Mammary , Watchful Waiting/standards , Young AdultABSTRACT
OBJECTIVE: In the UK RCR 5-point breast imaging system (UKS), radiologists grade mammograms from 1 to 5 according to suspicion for malignancy, however unlike BI-RADS, no lexicon of descriptors is published. The aim of this study was to determine whether strict categorisation of microcalcifications (MCC) according to BI-RADS was a better predictor of malignancy than the UKS and whether these descriptors could be used within the UKS. METHODS: A retrospective review of 241 cases, with MCC on mammography, who underwent biopsy was performed. Morphology, distribution, extent, UKS score, BI-RADS category and pathology were recorded. The positive predictive value (PPV) of each classification system for malignancy was calculated. RESULTS: 28.6% were diagnosed with DCIS/IDC. The PPV for malignancy using the UKS was 18.9%, 69.4%, 100% for M3-5 respectively (p < 0.001) and using ΒI-RADS morphology was amorphous: 7.1%, coarse heterogeneous: 33.3%, fine pleomorphic: 48.1% and fine linear/fine linear branching: 85.2% (p < 0.001). The PPV based on distribution was grouped: 14.2%, regional: 32.3%, diffuse: 33.3% and linear/segmental: 77.8% (p < 0.001). Combining all cases of benign-appearing, amorphous and grouped coarse heterogenous and grouped fine pleomorphic MCC gave a PPV of 12.8%. Combining regional, linear or segmental coarse heterogenous and fine pleomorphic and all fine linear/branching MCC resulted in a PPV of 83.3% for malignancy. CONCLUSION: Combining morphology and distribution of MCC is accurate in malignancy prediction. Use of BI-RADS descriptors could help standardise reporting within the UKS and an algorithm using these within the UKS is proposed. Better prediction would enable more appropriate counselling and help to identify discrepancies. ADVANCES IN KNOWLEDGE: No guidance exists on scoring of suspicious MCC in the UK breast imaging system. Use of BI-RADS morphologic/distribution descriptors can aid malignancy prediction. Findings other than morphology of MCC are important in malignancy prediction. An algorithm for use by the UK radiologist when evaluating MCC is provided.
Subject(s)
Breast Neoplasms/diagnostic imaging , Calcinosis/diagnostic imaging , Carcinoma, Ductal, Breast/diagnostic imaging , Adult , Aged , Aged, 80 and over , Breast Neoplasms/pathology , Calcinosis/pathology , Carcinoma, Ductal, Breast/pathology , Early Detection of Cancer , Female , Humans , Mammography/methods , Middle Aged , Neoplasm Grading , Predictive Value of Tests , Retrospective StudiesABSTRACT
Whole-body bone scintigraphy (bone scan) using a (99m)Tc-labelled pharmaceutical is one of the most commonly performed radionuclide examinations. In the normal patient, both the osseous components of the skeletal system as well as the kidneys and bladder are visualized. A superscan is defined as a bone scan which demonstrates markedly increased skeletal radioisotope uptake relative to soft tissues, in association with absent or faint genito-urinary tract activity. While a superscan is relatively uncommon, its recognition is important, as it is associated with a number of important underlying diseases. The purpose of this review article is to describe the causes and variable features of a superscan and depict patterns which may aid in defining the underlying cause for the scan. In addition, we will discuss other investigations that may help further to identify the underlying disease in such cases.
Subject(s)
Bone Diseases/diagnostic imaging , Image Enhancement/methods , Technetium , Whole Body Imaging/methods , Humans , Radionuclide Imaging , RadiopharmaceuticalsABSTRACT
Overuse injuries are a common cause of morbidity in athletes. They occur after repetitive microtrauma, abnormal joint alignment, and poor training technique without appropriate time to heal. Overuse injuries are frequent in the knee joint because of the numerous attachment sites for lower limb musculature and tendons surrounding the joint. MR imaging is regarded as the noninvasive technique of choice for detection of internal derangements of the knee. This article describes the characteristic findings on MR of the common overuse injuries in the knee, including patellar tendinopathy, iliotibial band syndrome, cartilage disorders, medial plica syndrome, and bursitis.